Arkolith/Insider Trading/SLXN/Form 4

Moringa Sponsor, LP

10% OwnerSilexion Therapeutics Corp (SLXN) · full profile →Form 4 · filed Jan 27, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2025Grant(A)450K$4.00$1.8M457K
Aug 7, 2025Other(J)6K—$07K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2025Other(J)935—$0372

Transaction Codes

A
Grant / award
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-26-000228) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML